Market Cap 19.86M
Revenue (ttm) 0.00
Net Income (ttm) -13.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 131,000
Avg Vol 8,844,134
Day's Range N/A - N/A
Shares Out 23.09M
Stochastic %K 31%
Beta 0.22
Analysts Sell
Price Target $3.00

Company Profile

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, inclu...

Industry: Biotechnology
Sector: Healthcare
Phone: 786 977 3380
Address:
1111 Lincoln Road, Suite 500, Miami Beach, United States
SPYmyQQQ
SPYmyQQQ Jan. 30 at 6:03 PM
🚀 New Signal ✅ 💊 $KTTA 🗓️ Jan 30, 2026 💵 Entry: $0.8800 🎯 Target (Opt.): $1.04 (+18.38%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
OAppelquist
OAppelquist Jan. 26 at 6:02 PM
$KTTA the Registrant hereby terminates the effectiveness of the Registration Statement. In addition, in accordance with undertakings made by the Registrant in the Registration Statement to remove from registration, by means of a post-effective amendment, any securities being registered which remain unsold at the termination of the offering, the Registrant hereby removes from registration all securities registered under the Registration Statement that remain unsold under the Registration Statement as of the date hereof. https://ir.pasithea.com/sec-filings/all-sec-filings##document-546-0001213900-26-007469-1
1 · Reply
FearlessAlex
FearlessAlex Jan. 24 at 9:23 PM
$KTTA In early December 2025, Pasithea announced the closing of a $60 million public offering of common stock (priced around 75 cents per share earlier in the process). This provided significant capital for ongoing clinical programs.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 19 at 6:52 PM
$KTTA RSI: 35.17, MACD: -0.0374 Vol: 0.13, MA20: 1.06, MA50: 0.96 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
UtahSUV
UtahSUV Jan. 17 at 1:52 AM
$KTTA can this shit do anything besides rob shareholders
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 15 at 10:02 AM
🚀 New Signal ✅ 💊 $KTTA 🗓️ Jan 15, 2026 💵 Entry: $0.9000 🎯 Target (Opt.): $1.04 (+15.08%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
DARKP00L
DARKP00L Jan. 13 at 12:37 PM
$KTTA 07:08 on Jan. 13 2026 Pasithea Therapeutics Provided Updated Timelines on Its Ongoing Clinical Trials in Advanced Cancer and Adult NF1-PN Patients #tradeideas
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 11 at 2:35 AM
$KTTA $1.44+
1 · Reply
SuperGreenToday
SuperGreenToday Jan. 10 at 6:48 AM
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 2 at 1:53 PM
🎯 Target Hit 🏁 📨 From Dec 19, 2025 💊 $KTTA 💵 Entry: $1.1000 ✅ Ext: $1.2700 💰 P/L: +15.45% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Latest News on KTTA
Why Is Pasithea Therapeutics Stock Surging On Thursday?

Sep 26, 2024, 8:56 AM EDT - 1 year ago

Why Is Pasithea Therapeutics Stock Surging On Thursday?


SPYmyQQQ
SPYmyQQQ Jan. 30 at 6:03 PM
🚀 New Signal ✅ 💊 $KTTA 🗓️ Jan 30, 2026 💵 Entry: $0.8800 🎯 Target (Opt.): $1.04 (+18.38%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
OAppelquist
OAppelquist Jan. 26 at 6:02 PM
$KTTA the Registrant hereby terminates the effectiveness of the Registration Statement. In addition, in accordance with undertakings made by the Registrant in the Registration Statement to remove from registration, by means of a post-effective amendment, any securities being registered which remain unsold at the termination of the offering, the Registrant hereby removes from registration all securities registered under the Registration Statement that remain unsold under the Registration Statement as of the date hereof. https://ir.pasithea.com/sec-filings/all-sec-filings##document-546-0001213900-26-007469-1
1 · Reply
FearlessAlex
FearlessAlex Jan. 24 at 9:23 PM
$KTTA In early December 2025, Pasithea announced the closing of a $60 million public offering of common stock (priced around 75 cents per share earlier in the process). This provided significant capital for ongoing clinical programs.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 19 at 6:52 PM
$KTTA RSI: 35.17, MACD: -0.0374 Vol: 0.13, MA20: 1.06, MA50: 0.96 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
UtahSUV
UtahSUV Jan. 17 at 1:52 AM
$KTTA can this shit do anything besides rob shareholders
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 15 at 10:02 AM
🚀 New Signal ✅ 💊 $KTTA 🗓️ Jan 15, 2026 💵 Entry: $0.9000 🎯 Target (Opt.): $1.04 (+15.08%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
DARKP00L
DARKP00L Jan. 13 at 12:37 PM
$KTTA 07:08 on Jan. 13 2026 Pasithea Therapeutics Provided Updated Timelines on Its Ongoing Clinical Trials in Advanced Cancer and Adult NF1-PN Patients #tradeideas
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 11 at 2:35 AM
$KTTA $1.44+
1 · Reply
SuperGreenToday
SuperGreenToday Jan. 10 at 6:48 AM
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 2 at 1:53 PM
🎯 Target Hit 🏁 📨 From Dec 19, 2025 💊 $KTTA 💵 Entry: $1.1000 ✅ Ext: $1.2700 💰 P/L: +15.45% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Mag7bull
Mag7bull Dec. 31 at 11:17 PM
$SIDU $SOPA my next top pick is $KTTA I had huge success in Sidu and Sopa and next one I loaded huge is ktta
1 · Reply
Risky_Behavoir
Risky_Behavoir Dec. 31 at 6:52 PM
$KTTA this one needs some kind of news. Otherwise it will trade sideways till they R\S
0 · Reply
Charles927
Charles927 Dec. 31 at 5:30 PM
$KTTA S☀️☀️N‼️💪🏾 EXTREMELY
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 30 at 10:16 PM
$KTTA Current Stock Price: $1.16
0 · Reply
PayoffPro
PayoffPro Dec. 26 at 8:58 AM
$KTTA This name increasingly trades on execution rhythm rather than speculation about possibilities. Execution gaps should narrow meaningfully. Momentum stabilizes only when delivery becomes predictable. Proof, rather than potential, becomes the key differentiator.
0 · Reply
TheLicensee
TheLicensee Dec. 25 at 8:09 AM
$KTTA Capital discipline has become the critical gating factor, while management calibrates resource allocation to real demand signals. Delivery cadence is becoming the real competitive edge.
0 · Reply
sscheel5729
sscheel5729 Dec. 23 at 5:34 PM
$KTTA Hype and volume died on this big time, Im still holding though. One piece of news could give us a big pop
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Dec. 23 at 2:25 PM
🌅 Watchlist part 2 ✅ $KAVL low $0.20 support; if above $0.30, has potential to $0.40 / $0.50 ✅ $AIRE mid $0.50 support; if above $0.70, has potential to $0.80 / $1.00 ✅ $CETX $2.30 support; if above $2.60, has potential to $2.80 / $3.20 🚨 The above tickers are not ideal for swing accumulation at current prices 🚨 ✅ Ideal long entries are near lower support levels 🎯 Ideal stop loss if price breaks below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $HOTH $KTTA still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Dec. 23 at 6:04 AM
🌅 Watchlist part 2 ✅ $CHR.X 1/50 reverse split → new price ~ $1.50 ✅ $BOXL 1/6 reverse split → new price ~ $3.48 🚨 The above tickers are not ideal for swing accumulation at current prices 🚨 ✅ Ideal long entries are near key support levels 🎯 Ideal stop loss if price breaks below current support 🚨 Avoid chasing longs into strength near resistance ⏳⏳ $HOTH, $KTTA still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D
0 · Reply
CoachHendo
CoachHendo Dec. 17 at 5:15 PM
0 · Reply
TxTrader283
TxTrader283 Dec. 16 at 4:41 PM
$KTTA when should compliance news be released?
0 · Reply
interloper
interloper Dec. 15 at 8:12 PM
$KTTA man did this stall out. Holding
0 · Reply